---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-038272"
form_type: "8-K"
ticker: "ONCY"
cik: "0001129928"
company_name: "ONCOLYTICS BIOTECH INC"
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:56:30.179108+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oncolytics Biotech completes redomestication to Nevada; adopts new equity plan and governance documents

## Summary
- Redomestication from Canada to Nevada completed; common stock continues trading on Nasdaq under ONCY.
- New CUSIP 68237V 103 and ISIN US68237V1035 effective April 1, 2026.
- Board adopted 2026 Incentive Award Plan with 6.5M initial shares plus annual evergreen increase up to 6% of outstanding.
- New indemnification agreements executed with all executive officers and directors.
- Risk factor update warns of reduced stockholder rights under Nevada law, including exclusive forum provisions and no cumulative voting.

## SEC filing metadata
- accession: 0001104659-26-038272
- form_type: 8-K
- ticker: ONCY
- cik: 0001129928
- company_name: ONCOLYTICS BIOTECH INC
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/tm2610715d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-038272
- JSON: https://secwatch.observer/filing/0001104659-26-038272.json
- Plain text: https://secwatch.observer/filing/0001104659-26-038272.txt

## Source-grounded claims
- claim_id: c9a1968f6ba4a562a9a0f9cb6664050d1699ac5d
  claim: ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.
  evidence_excerpt: On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.